July 19, 2017Diabetes/Metabolism Research and Reviews
ANGPTL8 (betatrophin) role in diabetes and metabolic diseases
Key result
This review highlights the physiological role of ANGPTL8 (betatrophin) in glucose homeostasis, lipid metabolism, and its association with diabetes, obesity, and metabolic syndrome.
Population
Human studies investigating metabolic diseases such as diabetes, obesity, and the metabolic syndrome
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
ANGPTL8 merits further mechanistic study in metabolic disease; leaves open its value as biomarker or therapeutic target.
Structured PICO
P
Population
Human studies investigating metabolic diseases such as diabetes, obesity, and the metabolic syndrome
E
Exposure
ANGPTL8 (betatrophin)
ANGPTL8 is a recently identified hormone involved in insulin resistance and lipid metabolism, making it a key target of investigation in metabolic diseases.
Cite This Study
Abu‐Farha et al. (2017) conducted a review in Diabetes, obesity, and metabolic syndrome. ANGPTL8 (betatrophin) was evaluated. This review highlights the physiological role of ANGPTL8 (betatrophin) in glucose homeostasis, lipid metabolism, and its association with diabetes, obesity, and metabolic syndrome.